Search 33,000+ CME courses
Back

Medscape, LLC

  • Arthritis, Rheumatoid
  • Janus Kinase Inhibitors

JAK Inhibitors in Rheumatoid Arthritis: Overcoming Challenges and Maximizing Impact

The goal of this activity is for learners to be better able to understand the MoA and clinical data surrounding the use of JAK inhibitors in the treatment of RA, enabling them to better individualize patient care and optimize therapeutic outcomes.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 0.5 creditsAMA PRA Category 1 Credit™Up to 0.5 creditsNursingUp to 0.5 creditsPharmacyUp to 0.5 credits

MOC types

ABIM — Medical KnowledgeUp to 0.5 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Faculty 2

All faculty

  • Jon Tyler Giles, MD

    Associate Professor of Medicine, Kao Autoimmunity Institute, Cedars-Sinai Medical Center

    Rheumatology

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 0.5 credits
  • MOC · Up to 0.5 points
  • Commercial Support
  • Released
    Dec 10, 2025
  • Last day to claim credit
    Dec 11, 2026 2 months left

Related courses

See all

Other providers’ courses on the same topic

More from Medscape, LLC

See all

This provider’s courses closest to this one